India has dropped its demand that telecom equipment suppliers hand over proprietary source code, in a relief for local telcos and multinationals such as Ericsson, Nokia and Cisco, but poses a setback for local gear-makers. After the latest change, manufacturers need to provide just a summary of internal security test results and confirm following the … Read more
Xavier Lorenzo | Moment | Getty Images Gen Z seems to have a case of economic malaise. Nearly half (49%) of its adult members — the oldest of whom are in their late 20s — say planning for the future feels “pointless,” according to a recent Credit Karma poll. A freewheeling attitude toward summer spending … Read more
Chinese quantitative hedge funds are stepping up efforts to hire science and engineering students in the US affected by President Donald Trump’s university funding cuts and tighter visa policies. Shanghai-based Mingshi Investment Management launched a special program last month to offer full-time jobs to students unable to finish their PhDs due to the recent US … Read more
These are some of the stocks posting the largest moves in midday trading. Source link
“We were always resilient in how we approached innovation. I think that’s what finally rewarded us,” Saldanha, chief executive officer and managing director of Glenmark Pharmaceuticals Ltd, told Mint in an exclusive interview. He was referring to one of the largest deals for an Indian biopharma firm after Glenmark’s US-based unit Ichnos Glenmark Innovation (IGI) … Read more
Construction on the Marriner S. Eccles Federal Reserve building in Washington, DC, US, on Wednesday, June 25, 2025. Al Drago | Bloomberg | Getty Images The Federal Reserve has brought in its inspector general to review a building expansion that has drawn fire from the White House, according to a source familiar with the issue. … Read more
Sun Pharma on Monday announced it has settled a patent row with American biopharma company Incyte Corporation over its hair-loss drug, paving the way for its launch in the US. The Mumbai-based drugmaker, embroiled in the lawsuit since last year, launched the specialty drug in the world’s largest pharmaceutical market on Monday. Leqselvi (oral deuruxolitinib) … Read more
Traders work on the New York Stock Exchange floor on Dec. 18, 2024. Spencer Platt | Getty Images For all the drama in the stock market of late, investors’ portfolio balances may not look too different from when President Donald Trump entered office. There have been some unnerving days amid the Trump administration’s tariff policies. … Read more
Tesla Inc. plans to poll shareholders on whether to invest in xAI, Elon Musk said after the Wall Street Journal reported SpaceX was prepared to funnel $2 billion into the Grok chatbot developer. The billionaire entrepreneur, responding to a post on X, said any decision to back the startup ultimately wasn’t his to make. Musk … Read more
Here are Monday’s biggest calls on Wall Street: UBS reiterates Tesla as sell UBS said the stock remains overvalued. “We believe TSLA remains fundamentally overvalued, but the price reaction will depend on Musk’s call comments.” Bank of America initiates Caris Life Sciences as buy The firm said the biotech company has a “best in class … Read more
